Ironwood Investment Counsel, LLC Pfizer Inc Transaction History

Ironwood Investment Counsel, LLC

$569 Million
Q3 2024

A detailed history of Ironwood Investment Counsel, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Ironwood Investment Counsel, LLC holds 20,057 shares of PFE stock, worth $518,072. This represents 0.1% of its overall portfolio holdings.

Number of Shares

20,057

Previous 23,932 16.19%

Holding current value

$518,072

Previous $669,000 13.3%

% of portfolio

0.1%

Previous 0.13%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$27.7 - $31.39 $107,337 - $121,636	-3,875 Reduced 16.19%	20,057 $580,000
Q2 2024 Aug 05, 2024	BUY	$25.26 - $29.6 $30,438 - $35,668	1,205 Added 5.3%	23,932 $669,000
Q1 2024 May 10, 2024	SELL	$25.89 - $29.73 $232,569 - $267,064	-8,983 Reduced 28.33%	22,727 $630,000
Q4 2023 Feb 07, 2024	SELL	$26.13 - $33.94 $233,314 - $303,050	-8,929 Reduced 21.97%	31,710 $912,000
Q3 2023 Nov 14, 2023	BUY	$32.09 - $37.51 $61,388 - $71,756	1,913 Added 4.94%	40,639 $1.35 Million
Q2 2023 Aug 08, 2023	SELL	$36.12 - $41.79 $161,673 - $187,052	-4,476 Reduced 10.36%	38,726 $1.42 Million
Q1 2023 May 11, 2023	SELL	$39.39 - $51.28 $49,040 - $63,843	-1,245 Reduced 2.8%	43,202 $1.76 Million
Q4 2022 Feb 01, 2023	SELL	$41.75 - $54.5 $247,076 - $322,531	-5,918 Reduced 11.75%	44,447 $2.28 Million
Q3 2022 Nov 08, 2022	SELL	$43.76 - $53.42 $529,933 - $646,916	-12,110 Reduced 19.38%	50,365 $2.2 Million
Q2 2022 Aug 04, 2022	SELL	$46.53 - $55.17 $104,041 - $123,360	-2,236 Reduced 3.46%	62,475 $3.28 Million
Q1 2022 May 09, 2022	SELL	$45.75 - $56.69 $2.9 Million - $3.59 Million	-63,399 Reduced 49.49%	64,711 $3.35 Million
Q4 2021 Feb 04, 2022	BUY	$41.32 - $61.25 $44,129 - $65,415	1,068 Added 0.84%	128,110 $7.56 Million
Q3 2021 Nov 04, 2021	BUY	$39.25 - $50.42 $145,931 - $187,461	3,718 Added 3.01%	127,042 $5.46 Million
Q2 2021 Aug 06, 2021	BUY	$35.91 - $40.68 $84,388 - $95,598	2,350 Added 1.94%	123,324 $4.83 Million
Q1 2021 May 03, 2021	SELL	$33.49 - $37.77 $778,341 - $877,812	-23,241 Reduced 16.12%	120,974 $4.38 Million
Q4 2020 Feb 11, 2021	BUY	$33.47 - $42.56 $427,010 - $542,980	12,758 Added 9.71%	144,215 $5.31 Million
Q3 2020 Nov 16, 2020	BUY	$31.75 - $37.25 $142,017 - $166,619	4,473 Added 3.52%	131,457 $4.82 Million
Q2 2020 Aug 11, 2020	BUY	$30.12 - $36.54 $370,235 - $449,149	12,292 Added 10.72%	126,984 $4.15 Million
Q1 2020 Apr 29, 2020	BUY	$27.03 - $38.62 $447,833 - $639,856	16,568 Added 16.88%	114,692 $3.74 Million
Q4 2019 Feb 10, 2020	BUY	$32.92 - $37.36 $51,816 - $58,804	1,574 Added 1.63%	98,124 $3.84 Million
Q3 2019 Nov 07, 2019	BUY	$32.49 - $42.13 $89,964 - $116,657	2,769 Added 2.95%	96,550 $3.47 Million
Q2 2019 Jul 29, 2019	BUY	$36.98 - $41.52 $17,195 - $19,306	465 Added 0.5%	93,781 $4.06 Million
Q1 2019 May 01, 2019	SELL	$37.5 - $41.2 $138,300 - $151,945	-3,688 Reduced 3.8%	93,316 $3.96 Million
Q4 2018 Jan 25, 2019	SELL	$38.47 - $43.86 $167,036 - $190,440	-4,342 Reduced 4.28%	97,004 $4.23 Million
Q3 2018 Oct 23, 2018	BUY	$34.47 - $41.81 $35,124 - $42,604	1,019 Added 1.02%	101,346 $4.47 Million
Q2 2018 Jul 26, 2018	BUY	$32.98 - $35.16 $136,867 - $145,914	4,150 Added 4.31%	100,327 $3.64 Million
Q1 2018 Apr 30, 2018	BUY	$31.91 - $37.02 $1.36 Million - $1.58 Million	42,680 Added 79.78%	96,177 $3.41 Million
Q4 2017 Feb 05, 2018	BUY	$33.26 - $35.29 $42,439 - $45,030	1,276 Added 2.44%	53,497 $1.94 Million
Q3 2017 Oct 30, 2017	BUY	$31.0 - $34.15 $119,753 - $131,921	3,863 Added 7.99%	52,221 $1.86 Million
Q2 2017 Aug 11, 2017	BUY	N/A	48,358	48,358 $1.65 Million

Others Institutions Holding PFE

# of Institutions

3,258

Shares Held

3.62B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $145B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ironwood Investment Counsel, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ironwood Investment Counsel, LLC with notifications on news.

Account

Ironwood Investment Counsel, LLC Pfizer Inc Transaction History